Texas Oncology - Central South — Austin, Texas

Texas Oncology - Central South is a clinical research site located in Austin, Texas, United States 78731.

Crixeo Health Trust Score: 81/100 (GOOD). This profile has not yet been claimed by the site owner.

Texas Oncology - Central South has participated in 19 clinical trials with 17 currently active.

Therapeutic areas: Metastatic Castration-Resistant Prostate Cancer, Metastatic Solid Tumor, Advanced Solid Tumor.

Sponsors: Zenith Epigenetics, Coherus Oncology, Inc., Pfizer.

Sponsor Feasibility Report

Trust Score: 81/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Texas Oncology - Central South?

Texas Oncology - Central South has a Crixeo Trust Score of 81/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Texas Oncology - Central South conducted?

Texas Oncology - Central South has 19 clinical trials on record, with 17 currently active. Their work covers Metastatic Castration-Resistant Prostate Cancer, Metastatic Solid Tumor, Advanced Solid Tumor.

Is Texas Oncology - Central South accredited by Crixeo Health?

Texas Oncology - Central South has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Texas Oncology - Central South?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.